Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04829669

A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric Emergency

Prospective Study to Assess, Outcomes and Healthcare Resource Use of Current Standard of Care for Patients With Moderate or sEvere MDD Requiring Urgent Symptom Control in a Psychiatric Emergency: POWER

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Janssen-Cilag Ltd. · Industry
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to describe the clinical outcomes (severity of depression, severity of suicidality \& frequency of suicidal thinking, suicide events) and quality of life (QoL) of participants with symptoms of major depressive disorder (MDD) that have current suicidal ideation with intent.

Conditions

Timeline

Start date
2024-04-30
Primary completion
2024-08-30
Completion
2024-08-30
First posted
2021-04-02
Last updated
2025-06-25

Source: ClinicalTrials.gov record NCT04829669. Inclusion in this directory is not an endorsement.

A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Ps (NCT04829669) · Clinical Trials Directory